PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Prescription medication · Nonsteroidal Anti-Inflammatory Drug (NSAID)

nabumetone

Also sold as Relafen. Nabumetone is used to relieve the symptoms of osteoarthritis and rheumatoid arthritis.

Data updated 2026-05-15

6,319
FDA reportsLightly reported
11
InteractionsSeveral interactions
$0.12
Generic price (NADAC)

What the data shows

nabumetone (Relafen) is a prescription Nonsteroidal Anti-Inflammatory Drug (NSAID), reported less often than most tracked drugs (6,319 FDA reports), with 11 documented drug interactions.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

nabumetone (Relafen) is a prescription Nonsteroidal Anti-Inflammatory Drug (NSAID). Nabumetone is used to relieve the symptoms of osteoarthritis and rheumatoid arthritis.

Nabumetone is a medicine that helps reduce pain and swelling. It is a type of NSAID (nonsteroidal anti-inflammatory drug).

Drug Pricing (NADAC)

Generic Price

$0.12/unit

Generic Available

Yes (7 manufacturers)

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

View Alternatives → Compare with Another Drug → Full Side Effects Report →

What it does

Nabumetone is used to relieve the symptoms of osteoarthritis and rheumatoid arthritis.

Common side effects

Diarrhea, Upset stomach, Abdominal pain

Key warnings

NSAIDs like nabumetone can increase your risk of heart attack or stroke, which can be fatal.

The sections below are summarized in plain English from nabumetone's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

Nabumetone works by reducing substances in the body that cause pain and inflammation. It blocks the production of prostaglandins. Prostaglandins contribute to inflammation and pain.

How to Take It

Take nabumetone exactly as your doctor tells you to. The usual starting dose is 1,000 mg once a day. You can take it with or without food. Your doctor may increase your dose to 1,500 mg to 2,000 mg per day, taken once or twice daily.

This is a plain-language summary of nabumetone's FDA labeling, not individualized dosing advice. Ask a pharmacist or prescriber before changing how you take this medication.

Pregnancy & Breastfeeding

Talk to your doctor if you are pregnant, may become pregnant, or are breastfeeding. Nabumetone may harm your unborn baby. It is not known if nabumetone passes into breast milk.

This is a plain-language summary of nabumetone's FDA labeling, not individualized advice. Ask a pharmacist or prescriber about pregnancy or breastfeeding on this medication.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is close to your next dose, skip the missed dose and continue with your regular schedule.

This is a plain-language summary of nabumetone's FDA labeling, not individualized advice. Ask a pharmacist or prescriber what to do about your specific missed dose.

Storage

Store nabumetone at room temperature, between 68° to 77°F (20° to 25°C).

Side Effects (from patient reports)

Based on 6,319 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for nabumetone, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for nabumetone each year to the FDA Adverse Event Reporting System (FAERS).

0200400600800 20042007201020132016201920222025 169

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where nabumetone sits

nabumetone has more FDA adverse-event reports than 29% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is nabumetone; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 6,319 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

6,319

Reports Mentioning Death

360

5.7% of reports — not proof of cause

Hospitalization Reports

1,504

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 4,463 (74%)
Male 1,581 (26%)

Age Distribution

0–17 45
18–44 664
45–64 1,956
65–74 781
75+ 390

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
2 PAIN 461
3 NAUSEA 372
4 FATIGUE 360
5 HEADACHE 316
6 ARTHRALGIA 307
7 DYSPNOEA 243
8 DIARRHOEA 238
9 PAIN IN EXTREMITY 226
10 CHRONIC KIDNEY DISEASE 223
11 DIZZINESS 222
12 ANXIETY 210
13 FALL 208
14 ACUTE KIDNEY INJURY 199
15 BACK PAIN 197
16 MALAISE 193

Reactions in Death Reports

DEATH 89
COMPLETED SUICIDE 77
TOXICITY TO VARIOUS AGENTS 39
PNEUMONIA 35
ACUTE KIDNEY INJURY 31
CARDIAC ARREST 29
RENAL FAILURE 29
CARDIO-RESPIRATORY ARREST 27
SEPSIS 26
PAIN 25

Reactions in Hospitalization Reports

PNEUMONIA 124
PAIN 119
DYSPNOEA 113
NAUSEA 105
FALL 101
ACUTE KIDNEY INJURY 97
ANXIETY 95
DEPRESSION 84
FATIGUE 84
BACK PAIN 77

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

NSAIDs like nabumetone can increase your risk of heart attack or stroke, which can be fatal. This risk may happen early in treatment and increases with longer use. You should not take this medicine if you are having heart bypass surgery (CABG). NSAIDs also increase the risk of serious stomach problems like bleeding and ulcers, which can be fatal. This can happen without warning, and older adults are at higher risk.

Known Drug Interactions

moderate warfarin

Warfarin The effects of warfarin and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than users of either drug alone. Caution should be exercised when administering nabumetone tablets with warfarin since interactions have been seen with other NSAIDs.

Mechanism: Both drugs increase the risk of bleeding in the stomach and intestines, and taking them together makes this risk much higher than taking either one alone. They work together in a way that makes serious bleeding more likely.

What to do: Use caution when taking these drugs together and watch closely for signs of bleeding. Your doctor may need to monitor your blood tests more often.

Methotrexate NSAIDs have been reported to competitively inhibit methotrexate accumulation in rabbit kidney slices. This may indicate that they could enhance the toxicity of methotrexate. Caution should be used when NSAIDs are administered concomitantly with methotrexate.

Mechanism: This drug may prevent the body from getting rid of methotrexate properly through the kidneys. This can cause methotrexate to build up to dangerous levels in the body.

What to do: Use caution when taking these medications at the same time. Your doctor should monitor you closely for signs of drug toxicity.

Diuretics Clinical studies, as well as postmarketing observations, have shown that nabumetone tablets can reduce the natriuretic effect of furosemide and thiazides in some patients.

Mechanism: Nabumetone can stop furosemide from working properly, making it harder for your body to remove extra salt and water.

What to do: Your doctor may need to check your blood pressure and look for signs of fluid buildup more often.

minor aspirin

Aspirin When nabumetone tablets are administered with aspirin, its protein binding is reduced, although the clearance of free nabumetone is not altered. The clinical significance of this interaction is not known; however, as with other NSAIDs, concomitant administration of nabumetone tablets and aspirin is not generally recommended because of the potential of increased adverse effects.

Mechanism: Taking these together can change how nabumetone travels in your blood and may increase your risk of harmful side effects.

What to do: You should generally avoid taking these two drugs together unless your doctor tells you otherwise.

minor lithium

Lithium NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance. The mean minimum lithium concentration increased 15% and the renal clearance was decreased by approximately 20%. Thus, when NSAIDs and lithium are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.

Mechanism: Nabumetone slows down how fast your kidneys clear lithium from your body, which causes lithium levels in your blood to rise.

What to do: Your doctor should monitor you carefully for signs of lithium toxicity and may need to adjust your lithium dose.

Check all your medications →

This is a plain-language summary of interactions documented in FDA labeling, not individualized advice. Ask a pharmacist or prescriber before combining medications.

Common Questions

Can I take nabumetone with aspirin?
It is generally not recommended to take nabumetone with aspirin due to the increased risk of side effects.
Will nabumetone affect my blood pressure medicine?
Nabumetone may reduce the effect of some blood pressure medicines. Talk to your doctor if you are taking an ACE inhibitor.
Can nabumetone affect lithium levels?
Yes, nabumetone can increase lithium levels in your blood. Your doctor may need to monitor your lithium levels more closely.
Is it okay to take antacids with nabumetone?
Taking antacids that contain aluminum will not significantly affect nabumetone.
What should I do if I experience severe stomach pain while taking nabumetone?
Stop taking nabumetone and contact your doctor immediately, as this could be a sign of a serious stomach problem.
Can nabumetone cause kidney problems?
Yes, nabumetone can sometimes cause kidney problems. Your doctor may monitor your kidney function while you are taking this medicine.
Can I drink alcohol while taking nabumetone?
It is best to avoid or limit alcohol consumption while taking nabumetone, as it may increase the risk of stomach bleeding.
How long does it take for nabumetone to start working?
It may take a few days or weeks for nabumetone to reach its full effect. Be patient and continue taking the medicine as prescribed.
What if nabumetone doesn't seem to be helping my pain?
Talk to your doctor if nabumetone is not effectively managing your pain. They may need to adjust your dose or consider other treatment options.
What are the common side effects of nabumetone?
The most commonly reported side effects of nabumetone include Diarrhea, Upset stomach, Abdominal pain, Constipation, Gas. Based on 6,319 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does nabumetone interact with other medications?
Yes, nabumetone has 11 known drug interactions. Notable interactions include warfarin, methotrexate, furosemide. Always inform your doctor about all medications you are taking.
What drug class is nabumetone?
nabumetone belongs to the Nonsteroidal Anti-Inflammatory Drug (NSAID) drug class. It requires a prescription (Rx). Nabumetone is used to relieve the symptoms of osteoarthritis and rheumatoid arthritis.
Is nabumetone safe during pregnancy?
Talk to your doctor if you are pregnant, may become pregnant, or are breastfeeding. Nabumetone may harm your unborn baby. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in Nonsteroidal Anti-Inflammatory Drug (NSAID)

Other drugs grouped near nabumetone - same-class peers and common alternatives.

Compare nabumetone vs abatacept side-by-side →

Medication Guides

Save on nabumetone

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for nabumetone

The FDA label for nabumetone (sold under brand names such as Relafen) classifies it as a prescription-only medication in the Nonsteroidal Anti-Inflammatory Drug (NSAID) class. Nabumetone is used to relieve the symptoms of osteoarthritis and rheumatoid arthritis. Official labeling lists 17 commonly reported side effects, including Diarrhea, Upset stomach, Abdominal pain.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 6,319 voluntary reports. The database also lists 11 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.12.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice, always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: September 23, 2025

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled and last refreshed May 2026. See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

All federal data sources used on this page